Photo of Dade Phelan
R Texas House · District 21

Rep. Dade Phelan

Compare
Total votes
5,101
all sessions
Attendance
94%
308 missed
Lower than 84% of chamber peers
With party
92%
of cast votes
Lower than 77% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 76% of chamber peers
Sponsored
300
bills & resolutions
Near the chamber average
Committees
2
assignments
5,101 roll-call votes

Voting record

Yea
4,699
voted in favor
Nay
173
voted against
Absent
308
missed votes
Total cast
5,101
across all sessions
Crossed party
373
votes against own party
This page
5,101
matching current filters
Bill
Description
Vote
Result
Tally
Date
HB 3910
Relating to the establishment of one or more supplemental county civil service commissions in certain counties.
Yea
Passed
110–38
May 7, 2019
HB 2586
Relating to political contributions and political expenditures made to or by political committees or other persons.
Yea
Passed
143–2
May 7, 2019
HB 4246
Relating to nonsubmetered billing for water or wastewater service.
Yea
Passed
147–0
May 7, 2019
HB 3652
Relating to the creation of a state repository for open educational resources by the Texas Higher Education Coordinating Board.
Yea
Passed
139–5
May 7, 2019
HB 4695
Relating to the administration of the Port of Port Arthur Navigation District of Jefferson County, including the authority to impose taxes.
Yea
Passed
117–30
May 7, 2019
HB 1888
Relating to temporary branch polling place hours of operation.
Yea
Passed
77–64
May 7, 2019
HB 4733
Relating to the creation of the Oak Farms Municipal Management District; providing authority to issue bonds; providing authority to impose assessments and fees.
Yea
Passed
106–41
May 7, 2019
HB 4548
Relating to the creation and operations of health care provider participation programs in certain counties.
Yea
Passed
142–5
May 7, 2019
HB 4390
Relating to the privacy of personal identifying information and the creation of the Texas Privacy Protection Advisory Council.
Yea
Passed
139–0
May 7, 2019
HB 1584
Relating to health benefit plan coverage of prescription drugs for stage-four advanced, metastatic cancer.
Yea
Passed
126–19
May 7, 2019
Showing 4,341 to 4,350 of 5,101 votes